Elucidating the role of gut microbes in CVD may provide future therapeutic strategies

3' education - Apr. 1, 2016 - VBWG Meeting at ACC 2016, Chicago, IL, USA - Stanley L. Hazen, MD, PhD - Cleveland Clinical Foundation, Cleveland, OH, USA

Stanley Hazen discusses the connection between our gut microbiome and physiologic processes relevant to heart disease, via a pathway involving the metabolite TMAO. Diet and therapies can affect TMAO levels, which influences platelet reactivity. Specifically targeting microbes that increase TMAO levels, may prove to be a future therapeutic strategy.

Educational information

Vascular Biology Working Group Meeting at ACC 2016, Chicago, IL, USA

Disclosures

Stanley L. Hazen, MD, PhD - Cleveland Clinical Foundation, Cleveland, OH, USA

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.